Archer Materials Builds Alpha-Prototype of Blood Potassium Sensor With Integrated Biochip; Shares Rise 5%
MT Newswires Live
Jan 30
Archer Materials (ASX:AXE) said it completed an alpha-prototype and laboratory demonstration of its blood potassium sensor with integrated biochip, according to a Friday Australian bourse filing.
The prototype demonstrated a potassium measurement accuracy within a 0.3 millimolar range in blood samples.
The company started the development of the beta-prototype, which will form the basis of negotiations with medical technology firms companies regarding potential licensing deals as well as engagement with contract medical device manufacturers and the initiation of clinical trials.
The firm's shares jumped past 5% in recent trading on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.